Across TCGA pan-cancer cohorts, CICP10 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated CICP10 data layer.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher CICP10 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated CICP10 expression acts as an unfavorable survival marker.
KIRC, ACC, and KICH are the cancer types where CICP10 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.